PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease

Published:2016-04-27 Issue:5 Volume:17 Page:630
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Aragonès Gemma,Auguet Teresa,Armengol Sandra,Berlanga Alba,Guiu-Jurado Esther,Aguilar Carmen,Martínez Salomé,Sabench Fátima,Porras José,Ruiz Maikel,Hernández Mercé,Sirvent Joan,Del Castillo Daniel,Richart Cristóbal

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/17/5/630/pdf

Reference56 articles.

1. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

2. Nonalcoholic fatty liver disease: From steatosis to cirrhosis

3. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

4. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications

5. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baicalin ameliorates alcohol-induced hepatic steatosis by suppressing SREBP1c elicited PNPLA3 competitive binding to ATGL;Archives of Biochemistry and Biophysics;2022-06

2. Effects of lifestyle interventions on epigenetic signatures of liver fat: Central randomized controlled trial;Liver International;2021-05-28

3. Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in Hepatocytes;Cellular and Molecular Gastroenterology and Hepatology;2021

4. PNPLA3 I148M is involved in the variability in anti-NAFLD response to exenatide;Endocrine;2020-08-30

5. Abnormal metabolic processes involved in the pathogenesis of non‑alcoholic fatty liver disease (Review);Experimental and Therapeutic Medicine;2020-08-28